CHINA PHARMA HOLDINGS, INC. Accretion (Amortization) of Discounts and Premiums, Investments
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Accretion (Amortization) of Discounts and Premiums, Investments of -$24.26 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments · last filed 2023-08-14
- CHINA PHARMA HOLDINGS, INC. accretion (amortization) of discounts and premiums, investments for the quarter ending 2022-03-31 was -$10.16K.
- CHINA PHARMA HOLDINGS, INC. accretion (amortization) of discounts and premiums, investments for fiscal 2021 was -$250.00K.
| Period end | Accretion (Amortization) of Discounts and Premiums, Investments 3 month | Accretion (Amortization) of Discounts and Premiums, Investments 6 month | Accretion (Amortization) of Discounts and Premiums, Investments 12 month |
|---|---|---|---|
| 2023-06-30 | -$24.26K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$10.16K 10-Q · filed 2023-05-12 | ||
| 2021-12-31 | -$250.00K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |